The Oncosearch | Oncotarget

Synergistic antitumor effect of a Î³-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma Research Paper

Xuran Yang, Wei Xia, Lin Chen, Chuan Xing Wu, Cathy C. Zhang, Peter Olson, Xiao Qi Wang

Published Oct 9, 2018 · Vol. 9, No. 79 · pp. 34996-35007

Erratum: Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells Errata

Joshua C. Curtin, Matthew V. Lorenzi

Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34856-34856

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells Research Paper

Norihiko Sasaki, Masashi Toyoda, Hisashi Yoshimura, Yoko Matsuda, Tomio Arai, Kaiyo Takubo, Junko Aida, Toshiyuki Ishiwata

Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34719-34734

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies Research Paper

Han Bit Baek, Alan P. Lombard, Stephen J. Libertini, Aleida Fernandez-Rubio, Ruth Vinall, Regina Gandour-Edwards, Rachel Nakagawa, Kathleen Vidallo, Kristine Nishida, Salma Siddiqui, Hiromi Wettersten, Yosef Landesman, Robert H. Weiss, Paramita M. Ghosh, Maria Mudryj

Published Oct 2, 2018 · Vol. 9, No. 77 · pp. 34567-34581

Heat shock protein 90 inhibitors overcome the resistance to Fms-like tyrosine kinase 3 inhibitors in acute myeloid leukemia Research Paper

Kazuhiro Katayama, Kohji Noguchi, Yoshikazu Sugimoto

Published Sep 28, 2018 · Vol. 9, No. 76 · pp. 34240-34258

Prominent role of histone lysine demethylases in cancer epigenetics and therapy Review

Avilala Janardhan, Chandrasekhar Kathera, Amrutha Darsi, Wajid Ali, Lingfeng He, Yanhua Yang, Libo Luo, Zhigang Guo

Published Sep 28, 2018 · Vol. 9, No. 76 · pp. 34429-34448

Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling Research Paper

Katelyn N. Nelson, April N. Meyer, Clark G. Wang, Daniel J. Donoghue

Published Sep 28, 2018 · Vol. 9, No. 76 · pp. 34306-34319

In tumor cells, thyroid hormone analogues non-immunologically regulate PD-L1 and PD-1 accumulation that is anti-apoptotic Research Perspective

Hung-Yun Lin, Yu-Tang Chin, Ya-Jung Shih, Yi-Ru Chen, Matthew Leinung, Kelly A. Keating, Shaker A. Mousa, Paul J. Davis

Published Sep 25, 2018 · Vol. 9, No. 75 · pp. 34033-34037

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

Maria Quanz, Urs B. Hagemann, Sabine Zitzmann-Kolbe, Beatrix Stelte-Ludwig, Sven Golfier, Cem Elbi, Dominik Mumberg, Karl Ziegelbauer, Christoph A. Schatz

Published Sep 25, 2018 · Vol. 9, No. 75 · pp. 34103-34121

The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimerâ€™s disease Research Paper

Soren Hayrabedyan, Krassimira Todorova, Marialuigia Spinelli, Eytan R. Barnea, Martin Mueller

Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 33884-33895

Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion Research Paper

Gesa von Olshausen, Maria Quasdorff, Romina Bester, Silke Arzberger, Chunkyu Ko, Maarten van de Klundert, Ke Zhang, Margarete Odenthal, Marc Ringelhan, Carien M. Niessen, Ulrike Protzer

Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 33947-33960

Can drug repurposing stop â€œchase and runâ€ between aldehydes and reactive sulfur species in anti-cancer therapy? News

Makoto Suematsu

Published Sep 18, 2018 · Vol. 9, No. 77 · pp. 34453-34454

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy Errata

Hongyan Yuan, Levy Kopelovich, Yuzhi Yin, Jin Lu, Robert I. Glazer

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33866-33866

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells Research Paper

Shogo Okazaki, Subaru Shintani, Yuki Hirata, Kentaro Suina, Takashi Semba, Juntaro Yamasaki, Kiyoko Umene, Miyuki Ishikawa, Hideyuki Saya, Osamu Nagano

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33832-33843

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Mathilde Guerin, Anthony GonÃ§alves, Yves Toiron, Emilie Baudelet, Matthieu Pophillat, Samuel Granjeaud, Patrick Fourquet, William Jacot, Carole Tarpin, Renaud Sabatier, Emilie Agavnian, Pascal Finetti, JosÃ© Adelaide, Daniel Birnbaum, Christophe Ginestier, Emmanuelle Charafe-Jauffret, Patrice Viens, FranÃ§ois Bertucci, Jean-Paul Borg, Luc Camoin

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33762-33777

Modulation of genomic and epigenetic end-points by celecoxib Research Paper

Alberto Izzotti, Sebastiano La Maestra, Rosanna T. Micale, Alessandra Pulliero, Marta Geretto, Roumen Balansky, Silvio De Flora

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33656-33681

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, Meritxell Galindo Casas, Melinda Au, Marjorie Bateman, Kevin C. Lindquist, Arvind Rajpal, David L. Shelton, Pavel Strop, Shu-Hui Liu

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33446-33458

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Tasaduq H. Wani, Sreeraj Surendran, Vishnu S. Mishra, Jaya Chaturvedi, Goutam Chowdhury, Anindita Chakrabarty

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33589-33600

Cancer stem cells in progression of colorectal cancer Review

Yujuan Zhou, Longzheng Xia, Heran Wang, Linda Oyang, Min Su, Qiang Liu, Jingguan Lin, Shiming Tan, Yutong Tian, Qianjin Liao, Deliang Cao

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33403-33415

Modeling and antitumor studies of a modified Lâ€“penetratin peptide targeting E2F in lung cancer and prostate cancer Priority Research Paper

Tazeem Shaik, Gulam M, Rather, Nitu Bansal, Tamara Minko, Olga Garbuzenko, Zoltan Szekely, Emine E. Abali, Debabrata Banerjee, John E. Kerrigan, Kathleen W. Scotto, Joseph R. Bertino

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33249-33257

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Synergistic antitumor effect of a Î³-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma Research Paper

Erratum: Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells Errata

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells Research Paper

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies Research Paper

Heat shock protein 90 inhibitors overcome the resistance to Fms-like tyrosine kinase 3 inhibitors in acute myeloid leukemia Research Paper

Prominent role of histone lysine demethylases in cancer epigenetics and therapy Review

Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling Research Paper

In tumor cells, thyroid hormone analogues non-immunologically regulate PD-L1 and PD-1 accumulation that is anti-apoptotic Research Perspective

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimerâ€™s disease Research Paper

Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion Research Paper

Can drug repurposing stop â€œchase and runâ€ between aldehydes and reactive sulfur species in anti-cancer therapy? News

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy Errata

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells Research Paper

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Modulation of genomic and epigenetic end-points by celecoxib Research Paper

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Cancer stem cells in progression of colorectal cancer Review

Modeling and antitumor studies of a modified Lâ€“penetratin peptide targeting E2F in lung cancer and prostate cancer Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Synergistic antitumor effect of a Î³-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma Research Paper

Erratum: Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells Errata

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells Research Paper

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies Research Paper

Heat shock protein 90 inhibitors overcome the resistance to Fms-like tyrosine kinase 3 inhibitors in acute myeloid leukemia Research Paper

Prominent role of histone lysine demethylases in cancer epigenetics and therapy Review

Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling Research Paper

In tumor cells, thyroid hormone analogues non-immunologically regulate PD-L1 and PD-1 accumulation that is anti-apoptotic Research Perspective

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimerâ€™s disease Research Paper

Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion Research Paper

Can drug repurposing stop â€œchase and runâ€ between aldehydes and reactive sulfur species in anti-cancer therapy? News

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy Errata

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells Research Paper

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Modulation of genomic and epigenetic end-points by celecoxib Research Paper

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Cancer stem cells in progression of colorectal cancer Review

Modeling and antitumor studies of a modified Lâ€“penetratin peptide targeting E2F in lung cancer and prostate cancer Priority Research Paper

Can drug repurposing stop â€œchase and runâ€ between aldehydes and reactive sulfur species in anti-cancer therapy? News